Objectives Whether clopidogrel should be added to aspirin for stroke prevention remained
controversial for the risk of hemorrhagic complications. This meta-analysis was aimed to …

Background and Purpose Antiplatelet therapy is widely used for the primary or secondary
prevention of stroke. Drugs like clopidogrel have emerged as alternatives for traditional …

Background It remains controversial whether dual antiplatelet therapy reduces stroke more
than aspirin alone. Aim We aimed to assess the effects of adding clopidogrel to aspirin on …

Antiplatelet therapy is universally recommended for the prevention of recurrent events in
patients with noncardioembolic ischaemic stroke or transient ischaemic attack (TIA), acute …

Background Clopidogrel was thought to be superior to aspirin for secondary prevention of
vascular diseases in clinical trials. In this study we assessed the safety and efficacy of …

The evaluation of antithrombotic agents for secondary stroke prevention has focused on
stroke reduction. The aim of this analysis was to focus specifically on the increase in …

Background Clopidogrel was superior to aspirin in patients with previous manifestations of
atherothrombotic disease in the CAPRIE study and its benefit was amplified in some high …

Background: Antiplatelet agents are the mainstay for secondary prevention of non-
cardioembolic stroke. This systematic review examined the safety and efficacy of short …

Aim. Though combination of clopidogrel added to aspirin has been compared to aspirin
alone in patients with stroke or transient ischemic attack, limited data exists on the relative …

Background Several clinical trials reported that clopidogrel was superior to aspirin in
secondary stroke prevention by reducing the risk of major adverse cardiovascular events …